UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

Journal of the American Society of Nephrology, 2014-02, Vol.25 (2), p.225-231

2014

Volltextzugriff (PDF)

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

American journal of physiology. Renal physiology, 2013-11, Vol.305 (9), p.F1288-F1297

2013

Volltextzugriff (PDF)

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

The Journal of pharmacology and experimental therapeutics, 2010-10, Vol.335 (1), p.61-69

2010

Volltextzugriff (PDF)

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Blood, 2012-08, Vol.120 (7), p.1449-1457

2012

Volltextzugriff (PDF)

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes

Metabolism, clinical and experimental, 2013-11, Vol.62 (11), p.1623-1632

2013

Volltextzugriff (PDF)

Characterization of LY2775240, a selective phosphodiesterase‐4 inhibitor, in nonclinical models and in healthy subjects

Clinical and translational science, 2021-05, Vol.14 (3), p.1037-1048

2021

Volltextzugriff (PDF)

Cytomegalovirus Encodes a Potent α Chemokine

Proceedings of the National Academy of Sciences - PNAS, 1999-08, Vol.96 (17), p.9839-9844

1999

Volltextzugriff (PDF)

Cytomegalovirus-Encoded β Chemokine Promotes Monocyte-Associated Viremia in the Host

Proceedings of the National Academy of Sciences - PNAS, 1999-09, Vol.96 (19), p.10881-10886

1999

Volltextzugriff (PDF)

Neuronal expression of fractalkine in the presence and absence of inflammation

FEBS letters, 1998-11, Vol.439 (3), p.203-207

1998

Volltextzugriff (PDF)

Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK

The Journal of immunology (1950), 2000-03, Vol.164 (6), p.2851-2856

2000

Volltextzugriff (PDF)

1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists

Bioorganic & medicinal chemistry letters, 2013-03, Vol.23 (5), p.1228-1231

2013

Volltextzugriff (PDF)

CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival

Transplantation, 2009-02, Vol.87 (3), p.360-369

2009

Volltextzugriff (PDF)

Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics

The Journal of biological chemistry, 2002-01, Vol.277 (4), p.2785-2789

2002

Volltextzugriff (PDF)

Optimization of 2-aminothiazole derivatives as CCR4 antagonists

Bioorganic & medicinal chemistry letters, 2006-05, Vol.16 (10), p.2800-2803

2006

Volltextzugriff (PDF)

RANTES Activation of Phospholipase D in Jurkat T Cells: Requirement of GTP-Binding Proteins ARF and RhoA

The Journal of immunology (1950), 1998-02, Vol.160 (4), p.1894-1900

1998

Volltextzugriff (PDF)

Chemokine Receptor CCR3 Function Is Highly Dependent on Local pH and Ionic Strength

The Journal of biological chemistry, 1997-11, Vol.272 (45), p.28206-28209

1997

Volltextzugriff (PDF)

Human Thymocytes Express CCR-3 and Are Activated by Eotaxin

Blood, 1999-05, Vol.93 (10), p.3233-3240

1999

Volltextzugriff (PDF)

RANTES-Induced T Cell Activation Correlates with CD3 Expression

The Journal of immunology (1950), 1998-01, Vol.160 (1), p.426-433

1998

Volltextzugriff (PDF)

Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein

The Journal of biological chemistry, 2002-01, Vol.277 (4), p.2785-2789

2002

Volltextzugriff (PDF)

CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells

The Journal of experimental medicine, 1997-09, Vol.186 (6), p.837-844

1997

Volltextzugriff (PDF)

HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines

The Journal of biological chemistry, 1999-07, Vol.274 (31), p.21569-21574

1999

Volltextzugriff (PDF)

Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications

The Journal of pharmacology and experimental therapeutics, 2012-06

2012

Volltextzugriff (PDF)

HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8

The Journal of biological chemistry, 1999-07, Vol.274 (31), p.21569-21574

1999

Volltextzugriff (PDF)

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

American journal of physiology. Renal physiology, 2013, Vol.74 (5)

2013

Volltextzugriff (PDF)

Addition of a 29 Residue Carboxyl-terminal Tail Converts a Simple HMG Box-containing Protein into a Transcriptional Activator

Journal of molecular biology, 1995-05, Vol.249 (1), p.11-28

1995

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(36)
Buchkapitel
(3)

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(22)
Animals
(15)
Mice
(13)
Biological And Medical Sciences
(9)
Immunology
(8)
Molecular Sequence Data
(8)
Biochemistry & Molecular Biology
(6)
Chemokines
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Mice, Inbred C57bl
(6)
Administration, Oral
(5)
Calcium - Metabolism
(5)
Cell Line
(5)
Medical Sciences
(5)
Pharmacology & Pharmacy
(5)
Amino Acid Sequence
(4)
Base Sequence
(4)
Cell Biology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease

Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes

Characterization of LY2775240, a selective phosphodiesterase‐4 inhibitor, in nonclinical models and in healthy subjects

Cytomegalovirus Encodes a Potent α Chemokine

Cytomegalovirus-Encoded β Chemokine Promotes Monocyte-Associated Viremia in the Host

Neuronal expression of fractalkine in the presence and absence of inflammation

Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK

1-(4-Phenylpiperazin-1-yl)-2-(1H-pyrazol-1-yl)ethanones as novel CCR1 antagonists

CXCR3 antagonism impairs the development of donor-reactive, IFN-gamma-producing effectors and prolongs allograft survival

Comprehensive mapping of poxvirus vCCI chemokine-binding protein. Expanded range of ligand interactions and unusual dissociation kinetics

Optimization of 2-aminothiazole derivatives as CCR4 antagonists

RANTES Activation of Phospholipase D in Jurkat T Cells: Requirement of GTP-Binding Proteins ARF and RhoA

Chemokine Receptor CCR3 Function Is Highly Dependent on Local pH and Ionic Strength

Human Thymocytes Express CCR-3 and Are Activated by Eotaxin

RANTES-Induced T Cell Activation Correlates with CD3 Expression

Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein

CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells

HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines

Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complications

HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

Addition of a 29 Residue Carboxyl-terminal Tail Converts a Simple HMG Box-containing Protein into a Transcriptional Activator

Suchergebnisse filtern